Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Median effective dose of continuous Ciprofol infusion with different dexmedetomidine doses during gastrointestinal endoscopy
ChiCTR2400093273Phase 4Recruiting
- Sponsor
- Shidong Hospital
- Start
- Dec 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol in None (3 arms), sponsored by Shidong Hospital. Primary endpoints: Blood pressure and Heart rate. Started Dec 2024; status: recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2400093273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093273.